ATE546143T1 - Mittel zur behandlung von glaukom mit einem rho- kinase-hemmer und prostaglandinen - Google Patents
Mittel zur behandlung von glaukom mit einem rho- kinase-hemmer und prostaglandinenInfo
- Publication number
- ATE546143T1 ATE546143T1 AT03791404T AT03791404T ATE546143T1 AT E546143 T1 ATE546143 T1 AT E546143T1 AT 03791404 T AT03791404 T AT 03791404T AT 03791404 T AT03791404 T AT 03791404T AT E546143 T1 ATE546143 T1 AT E546143T1
- Authority
- AT
- Austria
- Prior art keywords
- prostaglandins
- kinase inhibitor
- rho
- agent
- treating glaucoma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002250223 | 2002-08-29 | ||
PCT/JP2003/011004 WO2004019951A1 (ja) | 2002-08-29 | 2003-08-29 | Rhoキナーゼ阻害剤とプロスタグランジン類からなる緑内障治療剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE546143T1 true ATE546143T1 (de) | 2012-03-15 |
Family
ID=31972618
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03791404T ATE546143T1 (de) | 2002-08-29 | 2003-08-29 | Mittel zur behandlung von glaukom mit einem rho- kinase-hemmer und prostaglandinen |
Country Status (11)
Country | Link |
---|---|
US (4) | US20050245509A1 (de) |
EP (2) | EP2314299A1 (de) |
JP (1) | JP5174777B2 (de) |
KR (2) | KR101092048B1 (de) |
CN (1) | CN100425241C (de) |
AT (1) | ATE546143T1 (de) |
AU (1) | AU2003257588A1 (de) |
CA (1) | CA2496797C (de) |
ES (1) | ES2382733T3 (de) |
TW (2) | TWI337881B (de) |
WO (1) | WO2004019951A1 (de) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003257588A1 (en) * | 2002-08-29 | 2004-03-19 | Santen Pharmaceutical Co., Ltd. | REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS |
WO2004045644A1 (ja) * | 2002-11-18 | 2004-06-03 | Santen Pharmaceutical Co., Ltd. | Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤 |
US8722097B2 (en) | 2004-04-30 | 2014-05-13 | Allergan, Inc. | Oil-in-water method for making polymeric implants containing a hypotensive lipid |
US9498457B2 (en) | 2004-04-30 | 2016-11-22 | Allergan, Inc. | Hypotensive prostamide-containing biodegradable intraocular implants and related implants |
US7993634B2 (en) | 2004-04-30 | 2011-08-09 | Allergan, Inc. | Oil-in-oil emulsified polymeric implants containing a hypotensive lipid and related methods |
US7799336B2 (en) | 2004-04-30 | 2010-09-21 | Allergan, Inc. | Hypotensive lipid-containing biodegradable intraocular implants and related methods |
US8673341B2 (en) | 2004-04-30 | 2014-03-18 | Allergan, Inc. | Intraocular pressure reduction with intracameral bimatoprost implants |
KR101333970B1 (ko) * | 2005-05-19 | 2013-11-27 | 코와 가부시키가이샤 | 녹내장 예방 또는 치료제 |
JP4972551B2 (ja) * | 2005-06-21 | 2012-07-11 | 興和株式会社 | 緑内障の予防又は治療剤 |
WO2007007737A1 (ja) * | 2005-07-12 | 2007-01-18 | Kowa Co., Ltd. | 緑内障を予防又は治療する薬剤 |
WO2007026664A1 (ja) * | 2005-08-30 | 2007-03-08 | Asahi Kasei Pharma Corporation | スルホンアミド化合物 |
US7893050B2 (en) | 2005-10-26 | 2011-02-22 | Asahi Kasei Pharma Corporation | Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
WO2008036540A2 (en) | 2006-09-20 | 2008-03-27 | Boehringer Ingelheim International Gmbh | Rho kinase inhibitors |
US8071779B2 (en) * | 2006-12-18 | 2011-12-06 | Inspire Pharmaceuticals, Inc. | Cytoskeletal active rho kinase inhibitor compounds, composition and use |
US8455513B2 (en) | 2007-01-10 | 2013-06-04 | Aerie Pharmaceuticals, Inc. | 6-aminoisoquinoline compounds |
US8415372B2 (en) | 2007-02-27 | 2013-04-09 | Asahi Kasei Pharma Corporation | Sulfonamide compound |
AU2008220104B2 (en) | 2007-02-28 | 2012-09-27 | Asahi Kasei Pharma Corporation | Sulfonamide derivative |
CN101313926B (zh) * | 2007-05-30 | 2012-12-26 | 中央研究院 | 转录调控物组合物 |
CN101730690B (zh) | 2007-07-02 | 2013-01-16 | 旭化成制药株式会社 | 磺酰胺化合物及其结晶 |
US8207195B2 (en) | 2008-06-26 | 2012-06-26 | Inspire Pharmaceuticals, Inc. | Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds |
US8410147B2 (en) | 2008-06-26 | 2013-04-02 | Inspire Pharmaceuticals, Inc. | Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds |
US8450344B2 (en) | 2008-07-25 | 2013-05-28 | Aerie Pharmaceuticals, Inc. | Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
JP2012525386A (ja) | 2009-05-01 | 2012-10-22 | アエリエ・ファーマシューティカルズ・インコーポレーテッド | 疾患の治療のための二重機構阻害剤 |
AU2011279909A1 (en) * | 2010-07-19 | 2013-01-24 | Inspire Pharmaceuticals, Inc. | Bifunctional rho kinase inhibitor compounds, composition and use |
WO2012043891A1 (ja) | 2010-09-30 | 2012-04-05 | ダイトーケミックス株式会社 | 眼疾患処置薬 |
ES2684351T3 (es) * | 2011-02-04 | 2018-10-02 | Kowa Co., Ltd. | Terapia farmacológica para prevenir o tratar glaucoma |
TWI643619B (zh) * | 2012-07-13 | 2018-12-11 | 日商參天製藥股份有限公司 | 一種用於預防或治療青光眼或高眼壓症、或降低眼壓之醫藥組合物及其用途 |
US9339496B2 (en) | 2012-07-13 | 2016-05-17 | Santen Pharmaceutical Co., Ltd. | Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist |
CN109528721B (zh) * | 2013-03-15 | 2021-10-01 | 爱瑞制药公司 | 联合治疗 |
MY177958A (en) | 2013-10-31 | 2020-09-28 | Allergan Inc | Prostamide-containing intraocular implants and methods of use thereof |
KR20150090445A (ko) | 2014-01-29 | 2015-08-06 | 주식회사 이노칩테크놀로지 | 적층칩 소자 |
MY178880A (en) * | 2014-12-12 | 2020-10-21 | Kowa Co | Composition |
KR20180021741A (ko) * | 2015-05-29 | 2018-03-05 | 에쥐 세라피틱스, 인코포레이티드 | 시각 손실을 감소시키기 위한 조성물 및 방법 |
US10550087B2 (en) | 2015-11-17 | 2020-02-04 | Aerie Pharmaceuticals, Inc. | Process for the preparation of kinase inhibitors and intermediates thereof |
US9643927B1 (en) | 2015-11-17 | 2017-05-09 | Aerie Pharmaceuticals, Inc. | Process for the preparation of kinase inhibitors and intermediates thereof |
KR102568082B1 (ko) | 2016-08-31 | 2023-08-17 | 에어리 파마슈티컬즈, 인코포레이티드 | 안과용 조성물 |
AU2018243687C1 (en) | 2017-03-31 | 2020-12-24 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
EP4338751A3 (de) | 2017-12-21 | 2024-05-22 | Santen Pharmaceutical Co., Ltd. | Arzneimittel mit einer kombination aus sepetaprost und rho-assoziiertem coiled-coil mit einem proteinkinasehemmer |
TW201927303A (zh) | 2017-12-21 | 2019-07-16 | 日商參天製藥股份有限公司 | 歐米德尼培(Omidenepag)之組合 |
US10696638B2 (en) | 2017-12-26 | 2020-06-30 | Industrial Technology Research Institute | Compounds for inhibiting AGC kinase and pharmaceutical compositions comprising the same |
CN108815169A (zh) * | 2018-05-23 | 2018-11-16 | 中南大学湘雅医院 | 一种前列腺素类物质组合得到有效的青光眼治疗剂 |
US11427563B2 (en) | 2018-09-14 | 2022-08-30 | Aerie Pharmaceuticals, Inc. | Aryl cyclopropyl-amino-isoquinolinyl amide compounds |
WO2021182596A1 (ja) * | 2020-03-13 | 2021-09-16 | 興和株式会社 | 上眼瞼溝深化改善剤 |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2945008C2 (de) * | 1979-11-08 | 1981-08-20 | Lück, Werner, 4290 Bocholt | Stützelement für medizinische Lagerungszwecke |
US4599353A (en) * | 1982-05-03 | 1986-07-08 | The Trustees Of Columbia University In The City Of New York | Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma |
EP0286903B2 (de) * | 1987-04-03 | 2000-03-29 | The Trustees Of Columbia University In The City Of New York | Anwendung eines Prostaglandins in Mischung mit einem adrenergischen Blocker zur Verminderung des Augen-Innendruckes |
US4952581A (en) * | 1987-04-03 | 1990-08-28 | The Trustees Of Columbia University In The City Of New York | Use of a prostaglandin in combination with an adrenergic blocking agent for reduction of intraocular pressure |
CA1324129C (en) * | 1987-04-30 | 1993-11-09 | Ryuzo Ueno | Prostaglandins of the f series |
ATE82499T1 (de) * | 1987-09-18 | 1992-12-15 | R Tech Ueno Ltd | Okulare hypotensivagenzien. |
CA1334168C (en) * | 1988-04-26 | 1995-01-31 | Louis M. De Santis | Antiglaucoma compositions containing combinations of .alpha.-2 agonists and .beta. blockers |
JPH02108U (de) | 1988-06-14 | 1990-01-05 | ||
ES2213504T1 (es) | 1988-09-06 | 2004-09-01 | Pfizer Health Ab | Derivados de prostaglandina para el tratamiento del glaucoma o hipertension ocular. |
US5352708A (en) * | 1992-09-21 | 1994-10-04 | Allergan, Inc. | Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents |
US5510383A (en) * | 1993-08-03 | 1996-04-23 | Alcon Laboratories, Inc. | Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension |
AU720326B2 (en) * | 1995-12-21 | 2000-05-25 | Alcon Laboratories, Inc. | Use of certain isoquinolinesulfonyl compounds for the treatment of glaucoma and ocular ischemia |
CA2263425C (en) * | 1996-08-12 | 2008-09-30 | Yoshitomi Pharmaceutical Industries Ltd. | Pharmaceutical agent containing rho kinase inhibitor |
AU757910B2 (en) * | 1998-04-02 | 2003-03-13 | Genentech Inc. | Treatment of cardiac hypertrophy |
JP4212149B2 (ja) | 1998-06-11 | 2009-01-21 | 株式会社デ・ウエスタン・セラピテクス研究所 | 医薬 |
AU5198199A (en) * | 1998-08-17 | 2000-03-06 | Senju Pharmaceutical Co., Ltd. | Preventives/remedies for glaucoma |
SE9803761D0 (sv) * | 1998-11-04 | 1998-11-04 | Synphora Ab | Method to avoid increased iridial pigmentation during prostaglandin treatment |
WO2000057914A1 (fr) * | 1999-03-25 | 2000-10-05 | Santen Pharmaceutical Co., Ltd. | Agents permettant d'abaisser la tension oculaire |
US7217722B2 (en) | 2000-02-01 | 2007-05-15 | Kirin Beer Kabushiki Kaisha | Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
US20030018079A1 (en) | 2000-11-13 | 2003-01-23 | Richardson Helene | Treatment |
HN2002000067A (es) | 2001-03-23 | 2003-10-24 | Bayer Healthcare Llc | Inhibidores de la rho - quinasa. |
TWI336328B (en) | 2001-03-23 | 2011-01-21 | Bayer Healthcare Llc | Rho-kinase inhibitors |
WO2002100833A1 (fr) | 2001-06-12 | 2002-12-19 | Sumitomo Pharmaceuticals Company, Limited | Inhibiteurs de rho kinase |
MXPA04005674A (es) * | 2001-12-12 | 2004-10-15 | Pharmacia Corp | Metodo para tratar trastornos oftalmicos con antagonistas epoxi-esteroidales del receptor de aldosterona. |
AU2003257588A1 (en) * | 2002-08-29 | 2004-03-19 | Santen Pharmaceutical Co., Ltd. | REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND PROSTAGLANDINS |
WO2004045644A1 (ja) * | 2002-11-18 | 2004-06-03 | Santen Pharmaceutical Co., Ltd. | Rhoキナーゼ阻害剤とβ遮断薬からなる緑内障治療剤 |
WO2004105757A2 (en) * | 2003-05-29 | 2004-12-09 | Schering Aktiengesellschaft | Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy |
-
2003
- 2003-08-29 AU AU2003257588A patent/AU2003257588A1/en not_active Abandoned
- 2003-08-29 ES ES03791404T patent/ES2382733T3/es not_active Expired - Lifetime
- 2003-08-29 EP EP10192265A patent/EP2314299A1/de not_active Withdrawn
- 2003-08-29 EP EP03791404A patent/EP1541151B1/de not_active Expired - Lifetime
- 2003-08-29 TW TW092123857A patent/TWI337881B/zh not_active IP Right Cessation
- 2003-08-29 AT AT03791404T patent/ATE546143T1/de active
- 2003-08-29 TW TW099103157A patent/TWI350170B/zh not_active IP Right Cessation
- 2003-08-29 WO PCT/JP2003/011004 patent/WO2004019951A1/ja active Application Filing
- 2003-08-29 CA CA2496797A patent/CA2496797C/en not_active Expired - Fee Related
- 2003-08-29 CN CNB038233029A patent/CN100425241C/zh not_active Expired - Fee Related
- 2003-08-29 KR KR1020057003416A patent/KR101092048B1/ko not_active IP Right Cessation
- 2003-08-29 KR KR1020107029307A patent/KR101160780B1/ko active IP Right Grant
- 2003-08-29 US US10/525,986 patent/US20050245509A1/en not_active Abandoned
-
2009
- 2009-09-25 JP JP2009220230A patent/JP5174777B2/ja not_active Expired - Fee Related
- 2009-10-16 US US12/589,073 patent/US20100041671A1/en not_active Abandoned
- 2009-10-16 US US12/589,004 patent/US20100063060A1/en not_active Abandoned
-
2011
- 2011-10-25 US US13/280,684 patent/US20120040994A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2382733T3 (es) | 2012-06-13 |
JP2009298808A (ja) | 2009-12-24 |
KR20050057014A (ko) | 2005-06-16 |
WO2004019951A1 (ja) | 2004-03-11 |
KR20110004920A (ko) | 2011-01-14 |
TWI337881B (en) | 2011-03-01 |
KR101092048B1 (ko) | 2011-12-12 |
TW200409654A (en) | 2004-06-16 |
US20120040994A1 (en) | 2012-02-16 |
US20050245509A1 (en) | 2005-11-03 |
CA2496797C (en) | 2012-01-10 |
CN100425241C (zh) | 2008-10-15 |
US20100063060A1 (en) | 2010-03-11 |
TW201032807A (en) | 2010-09-16 |
CA2496797A1 (en) | 2004-03-11 |
TWI350170B (en) | 2011-10-11 |
AU2003257588A1 (en) | 2004-03-19 |
EP2314299A1 (de) | 2011-04-27 |
US20100041671A1 (en) | 2010-02-18 |
KR101160780B1 (ko) | 2012-06-27 |
JP5174777B2 (ja) | 2013-04-03 |
EP1541151B1 (de) | 2012-02-22 |
EP1541151A4 (de) | 2007-07-18 |
CN1684689A (zh) | 2005-10-19 |
EP1541151A1 (de) | 2005-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE546143T1 (de) | Mittel zur behandlung von glaukom mit einem rho- kinase-hemmer und prostaglandinen | |
NO20050851L (no) | Kaspase-inhibitorer og anvendelser derav | |
EA200801492A1 (ru) | Фармацевтическое применение замещенных амидов | |
MY147643A (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder | |
ATE467616T1 (de) | Verbindungen mit aktivität an der 11beta- hydroxasteroiddehydrogenase | |
MX2009009623A (es) | Inidol y bencimidazol amidas como inhibidores de la dehidrogenasa hidroxi-esteroide. | |
EA200101166A1 (ru) | Ингибиторы металлопротеаз | |
TW200634012A (en) | 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents | |
DE502004005033D1 (de) | Substituierte 2-aminotetraline zur behandlung von depressionen | |
ATE451361T1 (de) | Materialien und methoden zur behandlung von koagulationsstörungen | |
BR0211228A (pt) | Composto, composição farmacêutica e seus usos | |
ATE504294T1 (de) | Nichtnukleosidische reverse-transkriptase-hemmer | |
DE60135647D1 (de) | Zusammensetzungen zur normalisierung des zirkadianen rythmus | |
DE602007004849D1 (de) | Verwendung von allopurinol zur behandlung von palmarer/plantarer erythrodysästhesie | |
DE60305514D1 (de) | Neue verwendung von benzothiazolderivaten | |
HUP0400553A2 (hu) | Gyógyászati készítmények | |
WO2006125194A3 (en) | Piperazine derivatives and their uses as therapeutic agents | |
MX2021013942A (es) | Metodos de tratamiento de la urticaria cronica espontanea utilizando un inhibidor de la tirosina quinasa de bruton. | |
PA8525801A1 (es) | Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2 | |
WO2005016327A3 (en) | Treatment of sleep disorders with cholinesterase inhibitors | |
TW200503709A (en) | Itching treating agent containing piperidine derivative as active ingredient | |
DE602006020838D1 (de) | Medikamente zur prävention oder behandlung von herzversagen mit einem anticholinergikum | |
NO20053876D0 (no) | Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav | |
IS6555A (is) | Meðferð með aðskildum skömmtum sem hafa æðaskaðandi virkni | |
DE69910706D1 (de) | Medikament zur Behandlung von Glaukoma und ischämischer Retinopathie |